AVASTIN

Manufacturer:

Genentech

Name:

AVASTIN

HCPCS Code Descriptor:

Injection, bevacizumab, 10 mg

Category:

J Code

HCPCS:

J9035

NDC(s):

50242-0060-01, 50242-0061-01

Primary Type:

Oncology

Generic Status:

Single-Source

Route of Administration:

Intravenous

About:

AVASTIN is an Oncology drug manufactured by Genentech and administered via the Intravenous route of administration. The J Code: J9035 is aligned to the drug AVASTIN.

Avastin works in combination with certain chemotherapies and is used to prevent tumor growth in various types of cancer. By blocking the growth of new blood vessels that cancer cells depend on, Avastin should stop cancer cells from growing and reproducing. As of 2023, there are multiple biosimilar drugs available for Avastin including Mvasi (Q5107), Riabni (Q5123), and Zirabev (Q5118).